The firm, founded in 2005, focuses on later stage biopharmaceutical products, early stage medical devices, and laboratory infrastructure technologies. The team has been built over a decade and managed healthcare technology portfolios in venture capital funds. They partner with companies across all phases, from startup to public offerings, and provide deep domain expertise to help their portfolio navigate the complexity of the healthcare industry. New Leaf Venture Partners seeks to invest in visionary teams, businesses at the forefront of biology and innovation, and disruptive healthcare technologies across the entire healthcare system.